Mission Statement

Bionetek’s mission is to revolutionize cardiac diagnostics by commercializing our proprietary novel technology that prevents, diagnoses, differentiates, and tracks heart dysfunctions. 

We are steadfastly committed to the fight against heart dysfunctions, which is responsible for the annual deaths of over 800,000 in the United States and over 7 million worldwide. We strive to become the leader for non-invasive, diagnostic technology that detects these cardiac abnormalities with over 90% accuracy.



Background

Located in the heart of the "Biotech Corridor" in Southern California, Bionetek is housed in a 72,000 square foot, state-of-the-art manufacturing and development facility.

Bionetek develops, manufactures, and markets novel cardiac diagnostic systems for early diagnosis, differentiation, and follow-ups of heart dysfunction.  We are proud to release our 12-lead Crebro/Electrocardiography (CCG/ECG) product - the CARDx ECD (Early Cardiac Diagnostic System).

The CARDx ECD system employs a cardiac mathematical model that analyzes results against an extensive clinical database collected since 1980s. It can detect and differentiate heart dysfunction in an early, accurate, fast, and non-invasive manner.  For example, its diagnostic accuracy on CAD is presently 94%, comparable to a conventional coronary angiogram.

We believe that the CARDx ECD non-invasive cardiac diagnostic system will have a profound and long-reaching impact as an effective and accurate tool in the early detection of heart dysfunctions in the medical industry.



Career and Job Opening - Bionetek is currently hiring for the following positions.


Request More Information Form
E-mail info@bionetek.com
Call (626) 456-8080
3445 Fletcher Ave El Monte, CA 91731 Phone 626-458-8080 © 2009, Bionetek, All Rights Reserved. For international sales only.
•
 CARDx Technical White Paper now available for download
•
 Website Launched for Novel Early Cardiac Diagnostic System
  System Sales Manager /Specialist